Education
About Us
Working with TipRanks
Follow Us
LungLife AI, Inc. (GB:LLAI)
:LLAI
LLAI Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.95p - 36.20p
Previous CloseN/A
Volume24.20K
Average Volume (3M)84.43K
Market Cap
N/A
Enterprise Value2.63M
Total Cash (Recent Filing)$2.72M
Total Debt (Recent Filing)$346.00K
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Sep 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding25,485,983
10 Day Avg. Volume77,963
30 Day Avg. Volume84,434
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)15.05
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit57.28
Enterprise Value/Ebitda-0.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
LungLife AI, Inc. News
PremiumCompany Announcements
LungLife AI Enhances Advisory Team with New Appointment
PremiumCompany Announcements
LungLife AI Considers AIM Delisting Amid Funding Challenges
PremiumCompany Announcements
LungLife AI Advances Toward LungLB® Commercialization
PremiumCompany Announcements
LungLife AI Confident Amid Board ChangePremiumCompany Announcements
LungLife AI Revamps Stock Options Amid Cancer Test AdvancesPremiumCompany Announcements
LungLife AI Revamps Stock Options Plan
PremiumCompany Announcements
LungLife AI’s LungLB® Test Validated and Published
PremiumCompany Announcements
LungLife AI’s LungLB Test Gains Prestigious Recognition---
Options Prices
Currently, No data available
---
Ownership Overview
0.45% Insiders
―
Mutual Funds
― Other Institutional Investors
99.55% Public Companies and
Individual Investors
LLAI FAQ
What was LungLife AI, Inc.’s price range in the past 12 months?
LungLife AI, Inc. lowest share price was 0.95p and its highest was 36.20p in the past 12 months.
What is LungLife AI, Inc.’s market cap?
Currently, no data Available
When is LungLife AI, Inc.’s upcoming earnings report date?
LungLife AI, Inc.’s upcoming earnings report date is Sep 04, 2025 which is in 154 days.
How were LungLife AI, Inc.’s earnings last quarter?
LungLife AI, Inc. released its earnings results on Aug 22, 2024. The company reported -0.046p earnings per share for the quarter, missing the consensus estimate of N/A by -0.046p.
Is LungLife AI, Inc. overvalued?
According to Wall Street analysts LungLife AI, Inc.’s price is currently Overvalued.
Does LungLife AI, Inc. pay dividends?
LungLife AI, Inc. does not currently pay dividends.
What is LungLife AI, Inc.’s EPS estimate?
LungLife AI, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LungLife AI, Inc. have?
LungLife AI, Inc. has 25,485,983 shares outstanding.
What happened to LungLife AI, Inc.’s price movement after its last earnings report?
LungLife AI, Inc. reported an EPS of -0.046p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.545%.
Which hedge fund is a major shareholder of LungLife AI, Inc.?
Currently, no hedge funds are holding shares in GB:LLAI
---
Company Description
LungLife AI, Inc.
LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.
---
Technical Analysis
---